Characterizing extracellular vesicles of human fungal pathogens
- PMID: 40148564
- PMCID: PMC12035713
- DOI: 10.1038/s41564-025-01962-4
Characterizing extracellular vesicles of human fungal pathogens
Abstract
Since their discovery in 2007, there has been growing awareness of the importance of fungal extracellular vesicles (EVs) for fungal physiology, host-pathogen interactions and virulence. Fungal EVs are nanostructures comprising bilayered membranes and molecules of various types that participate in several pathophysiological processes in fungal biology, including secretion, cellular communication, immunopathogenesis and drug resistance. However, many questions remain regarding the classification of EVs, their cellular origin, passage across the cell wall, experimental models for functional and compositional analyses, production in vitro and in vivo and biomarkers for EVs. Here, we discuss gaps in the literature of fungal EVs and identify key questions for the field. We present the history of fungal EV discovery, discuss five major unanswered questions in fungal EV biology and provide future perspectives for fungal EV research. We primarily focus our discussion on human fungal pathogens, but also extend it to include knowledge of other fungi, such as plant pathogens. With this Perspective we hope to stimulate new approaches and expand studies to understand the biology of fungal EVs.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures
References
Publication types
MeSH terms
Grants and funding
- R01 AI152078/AI/NIAID NIH HHS/United States
- NA/Institut Pasteur
- 2021-67013-34258/U.S. Department of Agriculture (United States Department of Agriculture)
- 101873, 200208, 215599, 224323/Wellcome Trust (Wellcome)
- 2022/11123-5/Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation)
- ResistEV AAPG2021 CE35; Project FEVCOM AAPG2023 CE35/Agence Nationale de la Recherche (French National Research Agency)
- R01 AI183314/AI/NIAID NIH HHS/United States
- R35 GM136379/GM/NIGMS NIH HHS/United States
- R01 AI052733/AI/NIAID NIH HHS/United States
- E-26/201.602/2022 and E-26/211.300/2021/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro)
- 2022/02992-0/Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation)
- AI171093 and AI156104/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- NA/Centre National de la Recherche Scientifique (National Center for Scientific Research)
- MR/M026663/2, MR/N006364/2/RCUK | Medical Research Council (MRC)
- ANR-17-CAPS-0004-01 and ANR-17-EUR-0007/Agence Nationale de la Recherche (French National Research Agency)
- R35GM136379/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- NA/Agence Nationale de la Recherche (French National Research Agency)
- R01 HL059842/HL/NHLBI NIH HHS/United States
- R21 AI156104/AI/NIAID NIH HHS/United States
- AI052733-16, AI152078-01 and HL059842-19/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R01AI183314/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- R01 AI171093/AI/NIAID NIH HHS/United States
- 408843/2021-7 and 310778/2020-4/Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development)
- UIDB/04539/2020, UIDP/04539/2020 and LA/P/0058/2020/Secretaria Regional do Mar, Ciência e Tecnologia (Regional Secretariat for the Sea, Science and Technology)
- IOS 2020731/National Science Foundation (NSF)
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
